CRVO · CervoMed Inc.
$2.60
-0.04 (-1.52%)
At close · Aug 28
Going-concern doubt
— cleared Aug 7, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 7, 2026Market Cap
$39.76M
Shares
15.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-09-30 | — | |
| 8-K | 2026-08-10 | — | |
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-08-04 | — | |
| 8-K | 2026-07-14 | — | |
| 8-K | 2026-07-09 | — | |
| 8-K | 2026-06-22 | 2026-06-18 | |
| 8-K | 2026-06-22 | — | |
| 8-K | 2026-06-18 | 2026-06-16 | |
| 8-K | 2026-06-15 | — | |
| 8-K | 2026-06-10 | 2026-06-09 | |
| 8-K | 2026-06-09 | 2026-06-08 | |
| 8-K | 2026-05-18 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| DEF 14A | 2026-04-30 | 2026-06-08 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-04-07 | — | |
| 8-K | 2026-03-23 | — | |
| 8-K | 2026-03-19 | — | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-03-13 | 2025-12-31 | |
| 8-K | 2026-03-04 | — | |
| 8-K | 2026-02-18 | — | |
| 8-K | 2026-01-08 | 2026-01-07 | |
| 8-K | 2025-12-05 | 2025-12-01 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-29 | 2025-10-27 | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-10-08 | — | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-28 | — | |
| 8-K | 2025-06-25 | 2025-06-23 | |
| 8-K | 2025-05-19 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-29 | 2025-06-23 | |
| 8-K | 2025-04-18 | 2025-04-14 | |
| 8-K | 2025-04-07 | 2025-04-02 | |
| 8-K | 2025-03-18 | 2025-03-17 | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-11 | — | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-01-31 | — | |
| 8-K | 2024-12-10 | — | |
| 8-K | 2024-12-03 | — | |
| 8-K | 2024-11-27 | — |
Showing 1–50 of 187 filings
Key facts
CIK
1053691
CUSIP
15713L109
13F (30d)
36 filings
35 filers
Visit website
Investor relations